Will J&J Crush Wall Street?
Second-quarter earnings are upon us, and Dow component Johnson & Johnson is up at bat. Analysts are anticipating $1.29 per share for the health-care giant, but J&J has a history of surprises. Will J&J crush Wall Street tomorrow and what does it mean for investors? Watch and find out.
Instead of just picking an index fund, why not look to invest in individual Dow components? Fortunately, the Dow is loaded with companies with solid dividend payouts and highly sustainable business models built for the long haul. The 3 Dow Stocks Dividend Investors Need all have an X factor that make them stand out from their illustrious Dow peers. Download our special free report on these three companies by clicking here.
The article Will J&J Crush Wall Street? originally appeared on Fool.com.David Williamsonowns shares of Dendreon, Johnson & Johnson, and Pfizer, but he holds no other position in any company mentioned. Check out hisholdings and a short bio. The Motley Fool owns shares of Johnson & Johnson and Dendreon.Motley Fool newsletter serviceshave recommended buying shares of Pfizer and Johnson & Johnson and creating a diagonal call position in Johnson & Johnson. We Fools don't all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. Try any of our Foolish newsletter servicesfree for 30 days. The Motley Fool has adisclosure policy.